Acino will purchase the Middle East and African business of Teva's Cephalon Inc. subsidiary

Teva Pharmaceutical Industries Ltd.

Israel / Mid-Cap Biopharma ($1-$50 billion)

$34,774.1m on 10/21/2011 [market cap]

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Acino International AG

Switzerland / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced